Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 21, 2018
[Tolerance and pharmacodynamics phase Ⅰ clinical trial study of chimeric anti-CD20 monoclonal antibody IBI301 in Chinese patients with CD20-positive non-Hodgkin's lymphoma]
B Jiang, J Y Qi, M Y Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
June 28, 2017
[Outcomes of lenalidomide-based treatment for 57 patients of relapsed or refractory multiple myeloma]
S H Deng, Y Xu, W W Sui, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 11, 2016
[IGHV mutational statue in patients with splenic marginal zone lymphoma]
W J Yang, Z Yu, R Lyu, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
May 4, 2017
[Clinicopathologic characteristics of plasma cell myeloma with marrow fibrosis]
H L Li, K Ru, Q Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
December 4, 2023
[Angioimmunoblastic T-cell lymphoma with monoclonal B cell and plasma cell hyperplasia]
W W Yan, J Y Xu, L N Li, et al.
Zhonghua Yi Xue Za Zhi
|
June 12, 2023
[Clinical and biological features and prognosis of patients with leukemic non-nodal mantle cell lymphoma]
J W Chen, Y Wang, Y T Yan, et al.
Zhonghua Yi Xue Za Zhi
|
March 5, 2019
[The correlation between findings of whole-body diffusion weighted imaging and clinical result in patients with multiple myeloma]
W Y Huang, M Yang, W W Sui, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 23, 2018
[Clinical analysis of 24 patients of hairy cell leukemia treated by cladribine]
T Y Wang, Z J Li, R Lyu, et al.
Zhonghua Nei Ke Za Zhi
|
June 28, 2022
[Clinical characteristics and prognosis of 46 patients with macrofocal multiple myeloma]
W W Yan, H S Fan, J Y Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 23, 2018
[Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation]
W Y Huang, D H Zou, W Liu, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 21, 2018
[Tolerance and pharmacodynamics phase Ⅰ clinical trial study of chimeric anti-CD20 monoclonal antibody IBI301 in Chinese patients with CD20-positive non-Hodgkin's lymphoma]
B Jiang, J Y Qi, M Y Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
June 28, 2017
[Outcomes of lenalidomide-based treatment for 57 patients of relapsed or refractory multiple myeloma]
S H Deng, Y Xu, W W Sui, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 11, 2016
[IGHV mutational statue in patients with splenic marginal zone lymphoma]
W J Yang, Z Yu, R Lyu, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
May 4, 2017
[Clinicopathologic characteristics of plasma cell myeloma with marrow fibrosis]
H L Li, K Ru, Q Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
December 4, 2023
[Angioimmunoblastic T-cell lymphoma with monoclonal B cell and plasma cell hyperplasia]
W W Yan, J Y Xu, L N Li, et al.
Zhonghua Yi Xue Za Zhi
|
June 12, 2023
[Clinical and biological features and prognosis of patients with leukemic non-nodal mantle cell lymphoma]
J W Chen, Y Wang, Y T Yan, et al.
Zhonghua Yi Xue Za Zhi
|
March 5, 2019
[The correlation between findings of whole-body diffusion weighted imaging and clinical result in patients with multiple myeloma]
W Y Huang, M Yang, W W Sui, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 23, 2018
[Clinical analysis of 24 patients of hairy cell leukemia treated by cladribine]
T Y Wang, Z J Li, R Lyu, et al.
Zhonghua Nei Ke Za Zhi
|
June 28, 2022
[Clinical characteristics and prognosis of 46 patients with macrofocal multiple myeloma]
W W Yan, H S Fan, J Y Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 23, 2018
[Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation]
W Y Huang, D H Zou, W Liu, et al.
Page
of 7